Juntendo News

In an advancement that may guide clinical decision making, researchers have uncovered trends in atrial functional mitral regurgitation

Mitral regurgitation is a serious condition that can potentially lead to heart failure. While the primary causes of mitral regurgitation are known, researchers are only starting to understand a rare type of mitral regurgitation called atrial functional mitral regurgitation or AFMR. A retrospective study conducted in Japan examines outcomes of mitral valve surgery in AFMR. Findings highlight better outcomes in patients undergoing surgery compared to medical therapy, despite more severe initial conditions.

 

Characteristics and Treatment of Atrial Functional Mitral Regurgitation

Image caption: Researchers provide new insights into the causes of Atrial functional Mitral Regurgitation, a rare heart condition

Image credit: Nobuyuki Kagiyama of Juntendo University

License type: Original content

Usage restrictions: You are free to share and adapt the Infographic material but attribution is required, with a link to the news source.

 

Mitral regurgitation (MR) is a serious heart condition that often requires corrective surgery. It is characterized by the backflow or “regurgitation” of blood from the heart’s left ventricle into the left atrium. Atrial Functional Mitral Regurgitation (AFMR), characterized by normal mitral valve (MV) function and left ventricular function but with atrial dilation and defects in the ring-like structure that supports the MV leaflets (mitral annulus), poses diagnostic and therapeutic challenges due to its distinct pathophysiological mechanisms. Historically, studies on AFMR have been limited by small sample sizes and single-center data, leading to variability in reported prevalence and clinical outcomes.

To address this gap, a team of researchers led by Associate Professor Nobuyuki Kagiyama from the Department of Cardiovascular Biology and Medicine at Juntendo University Graduate School of Medicine, Japan, collaborated with Tomohiro Kaneko and Tohru Minamino, also from the same department, alongside Minoru Tabata from the Department of Cardiovascular Surgery at Juntendo University School of Medicine, and Yukio Abe from the Department of Cardiology at Osaka City General Hospital. Together, they conducted a retrospective study analyzing echocardiographic reports of patients who underwent transthoracic echocardiography. Their findings were published on August 15, 2024, in JAMA Network Open.

Called the REVEAL-AFMR study, the team analyzed a vast dataset comprising 225,163 echocardiographic reports from 177,235 patients who underwent transthoracic echocardiography in 2019. Through rigorous screening and validation processes, the study identified 1,007 cases of AFMR, accounting for 11.4% of all patients with MR in the study cohort.

The study’s findings shed light on several pivotal aspects of AFMR. Firstly, AFMR was found to predominantly affect elderly patients burdened with conditions like atrial fibrillation, enlarged left atria, and stiffened left ventricles. Secondly, the study’s evaluation of MV surgery outcomes upon a 3-year follow-up in 113 patients revealed a marked reduction in MR severity post-operation, correlating with substantially better clinical outcomes, including smaller rates of heart failure hospitalizations and all-cause mortality. These findings are the first report of outcomes after MV surgery in AFMR, and will be an important basis of decision- making in management strategies of AFMR.

“The study showed that patients with AFMR generally have poor prognoses, but those who underwent mitral valve surgery had significantly better outcomes. Notably, the surgical group had a three-year event rate of 18.3% compared to 33.3% in the non-surgical group. These findings underscore the importance of understanding AFMR and its treatment options. We believe this study provides critical insights into the real-world characteristics and treatment strategies for AFMR, paving the way for future trials to explore causal relationships and optimize patient care,” observes Kagiyama.

Although patients with AFMR are older, the study revealed that younger patients were most likely to receive corrective mitral valve surgery. Compared to those who remained on medical therapy, patients who underwent surgery also had more severe MR, had greater left atrium volume and suffered heart failure more frequently.

Although further research is required to prove the relationships definitively, the general trends in AFMR and outcomes of corrective mitral valve surgery in patients uncovered by this study are expected to guide clinicians in improved decision-making. The knowledge generated may also stimulate more scientific investigations into the origins of AFMR.

“This research addresses the significant challenge of underdiagnosis and undertreatment of AFMR by providing robust data on its clinical characteristics and outcomes. Healthcare providers can use this information to develop better screening protocols and treatment strategies, potentially improving the quality of life and survival rates for patients with AFMR. Additionally, this study could influence healthcare policies and resource allocation to ensure that patients with AFMR receive the attention and care they need,” Dr. Kagiyama explains. “Overall, our research contributes to a deeper understanding of AFMR and paves the way for future studies and clinical trials aimed at optimizing management and treatment for affected patients,” he concludes.

 

***

Reference

Authors	Nobuyuki Kagiyama, MD, PhD1; Tomohiro Kaneko, MD, PhD1; Masashi Amano, MD2, PhD; Yukio Sato, MD, PhD3; Yohei Ohno, MD, PhD4; Masaru Obokata, MD, PhD5; Kimi Sato, MD, PhD6; Taiji Okada, MD, PhD7; Naoki Hoshino, MD, PhD8; Kentaro Yamashita, MD, PhD9; Yuko Katsuta, MD, PhD10; Yuki Izumi, MD11; Mitsuhiko Ota, MD12; Yasuhide Mochizuki, MD, PhD13 ; Kaoruko Sengoku, MD, PhD14; Shunsuke Sasaki, MD, PhD15; Fukuko Nagura, MD, PhD16; Nanaka Nomura, MD17 ; Ryo Nishikawa, MD18; Nahoko Kato, MD, PhD19; Takahiro Sakamoto, MD, PhD20; Noriko Eguchi, MD, PhD21; Maiko Senoo, MD, PhD22; Mariko Kitano, MD, PhD23; Yoichi Takaya, MD, PhD24; Yoshihito Saijo, MD, PhD25; Hidekazu Tanaka, MD, PhD9; Kotaro Nochioka, MD, MPH, PhD10; Nami Omori, MD2; Minoru Tabata, MD, MPH, PhD26; Tohru Minamino, MD, PhD1; Naoki Hirose, MPH, PhD27; Kojiro Morita, MPH, PhD, RN, PHN28; Tomoko Machino-Ohtsuka, MD, PhD6; Victoria Delgado, MD, PhD29; Yukio Abe, MD, PhD17
Title of original paper	Clinical outcomes of mitral valve surgery in atrial functional mitral regurgitation: the REVEAL-AFMR registry
Journal	JAMA Network Open
DOI	10.1001/jamanetworkopen.2024.28032
Affiliations	1. Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan 2. Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Japan 3. Department of Cardiology, St. Marianna University School of Medicine, Kawasaki, Japan. 4. Department of Cardiology, Tokai University School of Medicine, Isehara, Japan. 5. Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. 6. Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan. 7. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan. 8. Department of Cardiology, Fujita Health University School of Medicine, Toyoake, Japan. 9. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University, Kobe, Japan. 10. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. 11. Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. 12. Department of Cardiovascular Center, Toranomon Hospital, Tokyo, Japan. 13. Division of Cardiology, Department of Medicine, Showa University, Tokyo, Japan. 14. Department of Cardiovascular Medicine Osaka University Graduate School of Medicine, Suita, Japan. 15. Division of Cardiology, Teine Keijinkai Hospital, Sapporo, Japan. 16. 36 Cardiovascular Medicine, Teikyo University, Tokyo, Japan. 17. Department of Cardiology, Osaka City General Hospital, Osaka, Japan. 18. Department of Cardiovascular, Renal, and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. 19. Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan. 20. Division of Cardiology, Shimane University, Izumo, Japan. 21. Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. 22. Department of Cardiology, Hirosaki University, Hirosaki, Japan. 23. Cardiovascular Center, Kitano Hospital, Osaka, Japan. 24. Department of Cardiovascular Medicine, Okayama University, Okayama, Japan. 25. Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan. 26. Department of Cardiovascular Surgery, Juntendo University School of Medicine, Tokyo, Japan. 27. Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. 28. Global Nursing Research Center, Graduate School of Medicine, University of Tokyo, Japan. 29. Department of Cardiology, Heart Institute, University Hospital Germans Trias i Pujol, Badalona, Spain

 

***

About Associate Professor Nobuyuki Kagiyama

Dr Nobuyuki Kagiyama is currently an Associate Professor at Juntendo University’s Department of Cardiovascular Medicine. He has published over 205 scientific articles in subjects including Cardiomyopathies, Heart Failure, Echocardiography, Cardiac Imaging, Advanced Machine Learning, and Artificial Intelligence in Medicine. Dr Kagiyama has previously worked as a researcher at West Virginia University, Washington University in St. Louis, University of Pittsburgh, The Sakakibara Heart Institute of Okayama, Kawasaki Medical School, Kameda Medical Center, and Musashino Red Cross Hospital.